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Natural Killer (NK) cells are capable of directly recognizing pathogens, 
pathogen-infected cells as well as transformed cells. NK cells recognize target cells 
using approximately one hundred germ-line encoded receptors, which display 
activating or inhibitory function. NK cell activation usually requires the engagement 
of more than one receptor and these may contribute distinct signaling inputs that are 
required for the firm adhesion of NK cells to target cells, polarization and the release 
of cytotoxic granules as well as the production of cytokines. Here we will discuss 
receptor-mediated mechanisms that counteract NK cell activation. We will first 
summarize the distinct intracellular inhibitory signaling pathways and how they can 
dominantly interfere with NK cell activation signaling events. In addition we will 
discuss mechanisms by which inhibitory receptors modulate cellular activation at the 
level of receptor-ligand interactions. Receptor-mediated inhibition of NK cell 
function serves three main purposes: Ensuring tolerance of NK cells to normal cells, 
enabling NK cell responses to aberrant host cells that have lost inhibitory ligand and 
finally allowing the recognition of certain pathogens that do not express inhibitory 
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Abbreviations:  
ITAM: Immunoreceptor Tyrosine-based Activating Motif; ITIM: Immunoreceptor 
Tyrosine-based Inhibition Motif; ITSM: Immunoreceptor Tyrosine-based Switch 
Motif; KIR: Killer Immunoglobulin-like Receptor; LFA-1: Leucocyte Function-
associated Antigen-1; NK: Natural Killer; MHC: Major Histocompatibility Complex; 
SHIP: SH2 domain containing inositol phosphatase 1; SHP-1: SH2 domain containing 
protein phosphatase 1; SLAM: Signaling Lymphocytic Activation Molecule; SAP: 
SLAM-associated protein; TAM receptors: TYRO3, AXL and MER receptors. 
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INTRODUCTION   
NK cells are a lymphocyte subpopulation capable of directly recognizing 
pathogens1 as well as pathogen-infected cells.2 In addition, NK cells have long been 
known to recognize transformed cells3 and they are increasingly recognized for their 
immune regulatory roles.4 NK cells can recognize their targets independent of 
somatically rearranged antigen-receptors and use around one hundred germ-line 
encoded receptors, which display activating or inhibitory function (for review see 5,6). 
While activating receptors are usually expressed on all NK cells, inhibitory receptors 
often show restricted expression patterns, which creates significant NK cell diversity. 
Further, NK cells acquire an effector cell program already in their tissue of origin. 
Bone marrow NK cells constitutively express high levels of Perforin, Granzyme B 
and IFNg mRNAs that are, however, not translated into protein.7,8 The trigger for the 
acquisition of this effector program is not known, but IL-17 signaling may play a 
role.9  
Subsequent to these developmentally programmed events, NK cells undergo 
significant phenotypic and functional changes based on environmental cues. Signaling 
by activation receptors becomes more efficient when NK cells recognize inherited 
Major Histocompatibility Complex (MHC) class I molecules (licensing)10 and they 
undergo further maturation  depending on the presence of other cell types.11 The 
effector capacity of NK cells is critically impacted by “priming” i.e. exposure to 
inflammation-induced cytokines, such as IL-15 in the case of viral 12 or IL-12 during 
bacterial infection.13 Priming leads to the translation of preformed Perforin and 
Granzyme B mRNA, enhances IFNg production, can induce the expression of 
additional NK cell receptors (NKp44) and renders signaling by activation receptors 
more effective.14 The firm adhesion to prospective target cells, the exocytosis of lytic 
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granules and the production and release of cytokines are then tightly controlled by 
signals received via inhibitory and activating NK cell receptors. The generally 
accepted view holds that activating and inhibition signals are integrated and that an 
excess of activating signals results in an effector response, which includes the release 
of lytic granules and inflammatory cytokines. A final adaptive process based on the 
stimulation of NK cells (e.g. by viral ligand such as MCMV m157) is the acquisition 
of memory-like features, which include increased longevity and improved effector 
capacities of NK cells.15  
 
1. NK cell activation receptors and signaling 
In order to discuss the importance and the mode of action of inhibitory receptors, we 
will first briefly summarize the various signaling pathways implicated in NK cell 
activation. 
 
Receptors associated with membrane bound signaling adaptors 
Similar to antigen receptors, multiple activation receptors expressed by NK cells 
depend on non-covalently associated, membrane anchored adaptors for signal 
transduction. Some of these adaptors (DAP12, FcRg     CD3z) contain one or 
three ITAMs (Immunoreceptor Tyrosine-based Activating Motif). NK cell receptors 
associated with DAP12 include human NKp44 and mouse NKG2D. Those associated 
with FcRg include mouse CD16 and NK1.1, while human CD16 or NKp30 are 
associated with CD3z      FcRg         . Receptor engagement activates 
Src family tyrosine kinases (including Lck and Fyn), which phosphorylate ITAMs in 
NK cells and allow the recruitment of the non-receptor tyrosine kinases Syk and 
Zap70. Subsequently, both trans membrane (Linker of activated T cells (LAT) and 
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Non-T cell activation linker (NTAL)) and cytosolic adaptors (SLP-76) form platforms 
for the activation of downstream molecules (such as phospholipase C (PLC)-γ1 and -
γ2, Vav2, Vav3 and Ras-family members) and signaling pathways (such as the 
mitogen-activated protein kinases (MAPK), c-Jun N-terminal kinase (JNK), 
extracellular signal-regulated kinase (ERK) and p38) that trigger NK cell mediated 
cytotoxicity and cytokine production.6  
In addition to ITAM bearing adaptors, NK cells also express DAP10, a homodimeric 
membrane-anchored signaling adaptor with an YxxM motif (in single-letter amino 
acid code, with x indicating non-conserved positions). DAP10 is associated with 
NKG2D or murine Ly49D and Ly49H. Similar to Ly49D and H, a short NKG2D 
isoform, which is only present in activated mouse NK cells, can pair with either 
DAP10 or DAP12. The DAP-10 YxxM motif is also present in receptors that co-
stimulate T cells, such CD28 or ICOS. Phosphorylated DAP10 recruits the p85 
subunit of phosphoinositide 3-kinase (PI3K) and the small adaptor Grb2 in 
association with Vav1.16  
 
NK cell activation independent of membrane bound signaling adaptors 
NK cells express additional activating cell surface receptors that function independent 
of an association with membrane-anchored adaptors. SLAM (Signaling Lymphocytic 
Activation Molecule) family receptors activate NK cells using semi-conserved 
S/T/I/VYxxV/I motifs (termed) present in the cytoplasmic portion of the receptor. 
The best understood receptor is 2B4 (CD244) but the function of other SLAM family 
receptors seems to be regulated in similar ways.17 Upon ligand binding and 
phosphorylation, the ITSM associates with small cytoplasmic adaptors such as SAP 
(SLAM-associated protein (SAP, also termed SH2D1A), EAT-2 and ERT. SAP 
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mediates activating function by coupling SLAM family receptors to the Src tyrosine 
kinase Fyn, which links SAP to the exchange factor Vav1. SAP-Fyn contributes to the 
formation of conjugates between NK cells and target cells.18 EAT-2 does not promote 
conjugate formation but accelerates polarization and exocytosis of cytotoxic 
granules,19 providing an explanation why both adaptors are needed for normal NK cell 
effector function. However, as detailed below, in certain cases SLAMs can act as 
inhibitory receptors. Additional receptors, including CD44, CD137, the TNF receptor 
family member CD27, CD160 and DNAM-1 contribute to NK cell activation 
signaling. However, the signaling events induced by these receptors are not well 
defined.  
 
Leucocyte Function-associated Antigen-1 (LFA-1) 
The b2 integrin LFA-1 (CD11a/CD18) plays a key role for NK cell function by 
mediating adhesion to target cells. To do so, LFA-1 must first undergo a 
conformational change to achieve a high-affinity binding state. In NK cells, LFA-1 
activation occurs by inside out signals from co-activating receptors such as NKG2D, 
DNAM-1 or 2B4,20 which then allows firm adhesion. Furthermore, in NK cells LFA-1 
has the ability to signal on its own and to function as a co-activating receptor. The 
engagement of LFA-1 by its ligand ICAM-1 on target cells is sufficient to polarize 
(but not release) lytic granules in human NK cells.21 Ligation of LFA-1 leads to 
phosphorylation and activation of Vav1 and the kinase Pyk2, which together with the 
Wiskott-Aldrich syndrome protein (WASp) regulate actin polymerization.22 While 
binding of ICAM-1-coated beads to mouse NK cells is also sufficient to induce 
reorganization of the actin cytoskeleton, lytic granules do not polarize.23 Thus 
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increased adhesive function of LFA-1 is an additional feature common to productive 
NK cell activation. 
 
Synergy and integration of NK cell activation signaling 
NK cell receptors have been classified into activation and co-activation receptors 
depending on whether an individual receptor is sufficient to trigger an effector 
response or whether receptor co-engagement is required. Based on stimulations of 
resting human NK cells using natural ligands, only CD16 qualified as an activation 
receptor. For all other receptors, pairwise engagement was needed to induce target 
cell lysis.24 A common consequence of the engagement of activating NK cell 
receptors is the phosphorylation of Vav family members. ITAM containing adaptors 
activate Vav2 and Vav3, while the YxxM containing adaptor DAP10 25 and switch 
motifs activate Vav1.18 Activation of Vav-1 is negatively regulated by the E3 
ubiquitin ligase c-Cbl and engagement of a single coactivation receptor is not 
sufficient to the inhibitory effect.26 The basis for synergy is that co-engagement of 
receptors (e.g. human 2B4 and NKG2D) phosphorylates two distinct tyrosine residues 
(Y113 and Y128) in the adaptor protein SLP76. Indeed, receptor combinations that do 
not synergize phosphorylate only one of the two tyrosines.27 Through the 
phosphorylation of two tyrosines, SLP76 integrates signals from distinct co-activation 
receptors and this is essential for Vav1 activation.26 
Although a corresponding analysis of murine NK cells is currently lacking, based on 
antibody-mediated stimulation, several receptors, including NK1.1, NKG2D, NKp46, 
Ly49H and CD16 can be considered activating in NK cells from naive mice.10 
Species-specific differences in adaptor usage and/or signal transduction may also 
contribute to this difference. Irrespective of this, the need for receptor co-engagement 
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to activate NK cells is reduced when NK cells have been primed in vivo or exposed to 
cytokines in vitro.14  
 
2. Receptor mediated inhibition of NK cell function 
Inhibitory receptors specific for MHC class I molecules 
The existence of inhibitory receptors was predicted based on negative effects of MHC 
class I molecules expressed by target cells on NK cell effector responses. Inhibitory 
receptors specific for classical MHC class I molecules expressed by human NK cells 
belong to the Killer Immunoglobulin-like Receptor (KIR) family. In addition, human 
NK cells express Leukocyte Immunoglobulin-like receptor B2 (LILRB1 also termed 
LIR-1), a pan MHC class I receptor and CD94/NKG2A, a receptor for non-classical 
HLA-E. Mouse NK cells also express CD94/NKG2A, which is specific for Qa-1b 
(the orthologue of human HLA-E), as well as Ly49 family receptors, which recognize 
classical and certain non-classical MHC class I molecules, such as H2-M3.28 In 
addition, NK cells express a significant number of additional inhibitory receptors, 
which recognize non-MHC class I ligands such as Sialic acid side chains (SIGLEC7 
and 9 in humans and SIGLEC-E in mice), CD155 (TIGIT), Cadherins (KLRG1) and 
Ceacam1 (homophilic). In general, these receptors prevent NK cell mediated damage 
of “normal-self” tissues and allow responses to aberrant cells that lack relevant 
markers of self. 
 
A standard model of receptor mediated inhibition  
Inhibitory receptors block NK cell function by interfering with activation signals. 
They are thought to act locally and block only signals from activation receptors with 
which they are co-aggregated. An illustration of this notion is that the proper 
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integration of activating and inhibitory receptor signals depends on the receptor-
ligand complexes to have similar dimensions. Indeed, activation and inhibitory ligand 
pairs co-localize when their respective sizes match, whereas they are segregated when 
their sizes differ.29,30 In addition, despite the diversity of early activating signaling 
pathways and events, inhibitory receptors interfere globally with NK cell activation.  
Typical receptors with inhibitory function are characterized by the presence of 
conserved I/VxYxxL/V motifs  (Immunoreceptor Tyrosine-based Inhibition Motif 
(ITIM)) in the cytoplasmic portion of the receptor. MHC class I receptor complexes 
contain two ITIMs, either in a tandem arrangement in monomeric KIRs or a single 
ITIM per subunit in homodimeric Ly49 receptors. Receptor engagement leads to 
ITIM phosphorylation by Src family kinases, including Lyn or Lck.31 Phosphorylated 
ITIMs recruit and activate the tandem SH2 protein phosphatases SHP-1 and SHP-2, 
whereby SHP-1 plays the essential role for the inhibitory function of MHC class I 
receptors.32 A key substrate of SHP-1 downstream of inhibitory KIR is Vav133  (Fig. 
1A). As discussed above Vav1 is phosphorylated by NK cell activation and Vav1 
dephosphorylation prevents the formation of downstream c-Cbl, Crk, p130CAS, C3G 
complexes,34 which have essential roles in inducing cell adhesion and cytolysis. If 
Vav2 and Vav3 proteins were also ITIM-SHP-1 targets, this would explain how 
inhibitory receptors could interfere globally with NK cell activation pathways. 
However this remains to be shown. 
Available evidence suggests that inhibitory signals block NK cell activation upstream 
of LFA-1 function and upstream of actin-dependent signals required for efficient 
receptor clustering and signaling. As mentioned above, signals delivered by co-
activation receptors are needed to improve LFA-1-dependent adhesion of resting NK 
cells to target cells.18 Such inside-out signals are blocked when the inhibitory CD94-
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NKG2A receptor is co-engaged.35 In addition, imaging analyses show that the 
engagement of inhibitory MHC class I receptors leads to a rapid formation of 
microclusters, which prevents microclustering of activating receptors.36 Moreover, 
inhibitory signaling efficiently prevents the polarization of lytic granules.37 Thus, 
rather than allowing activation signals to be fully established before acting on them, 
inhibitory receptors prevent activation signals from being propagated.  
 
An alternative mechanism of ITIM-dependent inhibition 
The analysis of biochemical events following target cell encounter by NK cells 
unexpectedly revealed that inhibitory receptor engagement not only prevents but also 
triggers unique signaling events, which are not detected when only activation signals 
are transduced. KIR or CD94/NKG2A engagement activated the tyrosine kinase c-
Abl, which lead to the phosphorylation of Crk.34 Further experiments showed that 
phosphorylated Crk is present at inhibitory, but not activating synapses, and that Crk 
phosphorylation is needed for NK cell inhibition (Fig. 1B). This is explained by a role 
for unphosphorylated Crk in the clustering and the signaling by activating NK cell 
receptors such as CD16.38 Even more surprisingly, counter to an assumed need for co-
aggregation with activation receptors, engagement of CD94-NKG2A by HLA-E alone 
was sufficient to induce Crk phosphorylation,38 suggesting that at least CD94/NKG2A 
receptor complexes can exert autonomous signaling function.   
 
Inhibition via immune receptor tyrosine based switch motifs (ITSM)  
Inhibitory receptor signaling can also occur in the absence of a consensus ITIM. 
Selected examples of such receptors and their mode of action are discussed below. 
Even though SLAM family receptors, including 2B4, have been introduced as 
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activating receptors, under certain circumstances these receptors can exert inhibitory 
roles. For example, in NK cells from patients with X-linked lympho proliferative 
(XLP) disease, 2B4 functions as an inhibitory receptor. XLP patients have 
inactivating mutations in the SAP-encoding SH2D1A gene.39 In the absence of SAP, 
SLAM receptors interact with SHP-1, SHP-2, and SHIP-1 (SH2 domain containing 
inositol phosphatase 1). Functional experiments using a SAP-deficient B cell line, 
showed that 2B4-dependent inhibition of BCR signaling was mediated by SHIP-118 
(Fig. 1C). While 2B4 engagement induced SHIP-1 phosphorylation, it is unclear how 
2B4 recruits SHIP-1. Once activated by phosphorylation and recruited to the plasma 
membrane, SHIP-1 hydrolyzes the 5' phosphate of phosphatidylinositol (3,4,5)-
triphosphate (PIP3), and thus prevents the activation of AKT and PLCg.40 While it is 
clear that SLAMs have inhibitory function when SH2D1A is mutated, an intriguing 
unresolved question is how SLAMs receptors can act as inhibitory receptors when 
NK cells express SAP. According to one model, the inhibitory versus activating 
function of 2B4 in NK cells is regulated by the expression levels of 2B4, the 
availability of intracellular SAP and the density of CD48 ligand.41  
Another prominent example of a receptor using an ITSM for cellular inhibition is 
PD1. This receptor is known for its role in limiting T cell mediated damage in 
situations of chronic stimulation and its presence is a hallmark feature of exhausted T 
cells. PD-1 is not expressed on normal NK cells but is induced by chronic stimulation 
such as the presence of multiple myeloma42 or Hepatitis C Virus infection.43 The 
cytoplasmic tail of PD-1 contains both an ITIM and an ITSM, whereby the latter is 
required for PD-1-mediated inhibition.44 PD-1 engagement does not recruit SAP but 
significantly enhances the recruitment of SHP-2. Further, proximity of PD-1 to the T 
cell receptor is essential for the inhibitory function, which chiefly impacts PI3K/Akt 
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activity.45 Thus, ITSM-mediated inhibition is mediated via more than one pathway. It 
remains to be seen whether distinct types of ITSM-mediated inhibition are operative 
in NK cells. 
 
ITIM and switch motif independent NK cell inhibition   
There is also emerging evidence for inhibitory effects that operate independent of 
ITIM and ITSM motifs. A recent study reported a novel Cbl-b/TAM (TYRO3, AXL 
and MER) receptor-dependent inhibitory pathway for NK cell activation.46 
Engagement of TAM receptor tyrosine kinases with their endogenous ligand Gas6 
suppressed proliferation and IFN-γ production by NK cells induced by the NKG2D 
receptor. Gas6 induced the recruitment of the ubiquitin ligase Cbl-b to the 
cytoplasmic domain of TAM receptors, which lead TAM ubiquitination and 
suppression of NK cell activation by NKG2D and other receptors (Fig. 1D). Indeed, 
Cbl-b−/− NK cells were resistant to negative regulation of NK cells by Gas6, 
demonstrating that Cbl-b acts downstream of TAM receptors. A possible 
developmental basis for these defects could be excluded, since a small-molecule 
TAM kinase inhibitor readily abolished the inhibitory effect of Gas6, and enhanced 
NK cell cytotoxicity towards cancer cells.46 How the inhibitory TAM/Cbl-b pathway 
counteracts the function of NK cell activation receptors remains to be determined. 
 
3. Modification of NK cell activation at the level of receptor-ligand interactions 
Inhibitory ligands expressed in trans and cis  
Inhibitory receptors strongly counteract effector responses when interacting with 
ligands present on opposing cell membranes (trans interaction). However, some 
inhibitory receptors can also interact with ligand present on the NK cell’s own cell 
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membrane (cis interaction).  This was first described for MHC class I-specific Ly49 
receptors in the mouse.47 A considerable fraction of inhibitory Ly49 receptors is 
constitutively associated with MHC class I in cis. These cis complexes appear 
relatively stable and are not thought to contribute to inhibitory signaling. Thus, cis 
binding effectively reduces the availability of inhibitory receptors to bind MHC class 
I on target cells. Consequently, the function of inhibitory receptors is reduced, which 
lowers the threshold for NK cell activation (Fig. 2A). Cis/trans binding modes have 
been reported for additional inhibitory NK cell receptors including human LILRB148  
and Siglecs.49 
 
Competition between activating and inhibitory receptors  
Activation can also be reduced based on a competition between activating and 
inhibitory receptors for the same ligand expressed on other cells. The most prominent 
model is the competitive inhibition of CD28 activation by CTLA-4. Here, the co-
stimulatory CD28 and the co-inhibitory CTLA-4 expressed by T cells compete for 
CD80/CD86 on antigen presenting cells (APC). Inhibition is based on the up 
regulation of CTLA-4 upon (chronic) T cell activation and on the fact that the affinity 
of CTLA-4 for CD80/CD86 exceeds that of the co-stimulatory CD28.  
CD28 and CTLA-4 expression is also observed on NK cells, at least in the mouse and 
following in vitro culture in IL-2.50 NK cell activation by plate-bound CD80 induced 
IFNg production, which was strongly reduced when NK cells lacked CD28. 
Conversely, IFNg production was significantly increased when NK cells lacked 
CTLA-4,50 indicating that CD28 and CTLA-4 have opposing roles also in NK cells. 
Thus, competitive effects, similar to the ones operating in T cells, may directly reduce 
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NK cell activation. However, the precise contribution of competition and signaling to 
the inhibitory function of CTLA-4 remains to be addressed, not only in NK cells. 
Similar to the situation described above, NK cells co-express the co-activation 
receptor DNAM-1 (CD226) and the ITIM-bearing TACTILE (CD96) that both bind 
CD155. Since CD96 has a higher affinity for CD155 as compared to the activating 
DNAM-1,51 DNAM-1 function is likely reduced due to competition for CD155 
binding 52 (Fig. 2B). However, since CD96 can deliver inhibitory signals, the relative 
contribution of competition and signaling remains to be determined. One additional 
aspect of CD96 function may be worth mentioning. CD96 engagement reduced 
cytokine production but not killing.51 This is similar to the absence of CD45, a 
membrane-anchored protein tyrosine phosphatase, which blunted cytokine production 
but had a minor effect on cytolytic activity. Selective effects of inhibitory receptors 
on a subset of effector functions may be explained by a lower activation threshold for 
cytotoxicity as compared to IFNγ production.53 
 
4. Non-conventional roles of inhibitory NK cell receptors 
The response of activation receptors to stimulation can vary significantly between 
individual NK cells from the same donor. NK cells, which can recognize MHC class 
I, respond efficiently to stimulation, while NK cells, which cannot recognize MHC 
class I respond poorly.10,54,55 The improved responsiveness of NK cell activation 
receptors, which depends on ITIM-dependent signals from MHC class I receptors, is 
referred to as “licensing”.10 The molecular mechanism for licensing is still debated. 
One possible mechanism, referred to as “disarming”, is that activation receptors 
become by default responsive to stimulation at some point during NK cell 
development. ITIM-dependent inhibitory signals would neutralize activation signaling 
	 16	
and this would keep the activation pathway competent to respond to subsequent 
stimulation. If NK cells cannot bind MHC class I, persistent stimulation would 
eventually render activation pathways non-functional.56 An alternative “arming” 
scenario proposes that NK cell activation receptors are by default poorly responsive to 
stimulation and signals from MHC class I receptors are needed to render activation 
receptors competent to signal.56 Here, inhibitory receptors and consequently ITIM-
dependent signals instruct NK cells. The finding that CD94-NKG2A engagement can 
induce the activity of c-Abl and phosphorylate Crk38 is consistent in principle with 
such a scenario. Irrespective of the mechanism, the improved functionality of 
activation receptors is essential for efficient NK cell responses to cells that lack MHC 
class I expression. 
 
Perspectives 
The mode of action of inhibitory receptors is still incompletely understood. This 
applies both to the understanding of intracellular signaling events as well as the 
relative importance of competitive inhibition of cellular activation. Further, it was 
thought that inhibitory receptors act globally but recent work has raised the possibility 
that some inhibitory receptors may act on specific activation pathways and selected 
effector functions. In addition, there is some evidence that receptors identified based 
on their inhibitory function can perform additional roles. Examples include NK cell 
licensing, a possible co-stimulatory role of KIR in CD4 T cells57 and evidence that 
inhibitory receptors improve NK cell survival.58,59 The central role of these inhibitory 
pathways is to ensure self-tolerance i.e. to prevent NK cell responses to cells that 
normally express specific markers of “self”, such as MHC class I molecules, thereby 
allowing responses to aberrant self cells that have lost relevant markers of self. 
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Moreover, recent data raise the possibility that inhibitory receptors play a role for the 
detection of “non-self” cells. NK cells can kill Cryptococcus and Candida based on 
NKp30-dependent activation1. It seems reasonable to assume that NKp30-mediated 
NK cell activation can proceed since the fungal cells lack MHC class I molecules and 
likely other inhibitory ligands characteristic of human cells. Since NK cells exert 
protective roles in other fungal infections, absence of receptor-mediated inhibition 
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Fig. 1. Receptor-mediated activating and inhibitory signaling 
A Signaling by the activating NKG2D-DAP-10 receptor complex (via YxxM 
motifs) leads to the phosphorylation of Vav1, which is essential for firm adhesion to 
target cells and the execution of an effector response. Co-engagement of inhibitory 
KIR (Killer Immunoglobulin-like receptors) leads to the phosphorylation of ITIMs 
(ITIM, Immunoreceptor tyrosine-based inhibition motif), which mediate inhibitory 
signaling by recruiting the protein tyrosine phosphatase SHP-1. Activated SHP-1 
dephosphorylates and thus inactivates Vav1. 
B Signaling by the activating CD16-CD3z receptor complex (via ITAMs) 
depends on the adaptor protein Crk. Inhibitory KIR activates the c-Abl tyrosine 
kinase, which phosphorylates and consequently inactivates Crk.  
C In the absence of the cytosolic adaptor SAP (SLAM-associated protein), the 
ITSM (Immunoreceptor tyrosine-based switch motif) present in 2B4 can initiate 
inhibitory signaling by recruiting (directly or indirectly) SHIP-1, an inositol 
phosphatase. SHIP hydrolyzes the 5' phosphate from phosphatidylinositol (3,4,5)-
triphosphate (PIP3), thus preventing the activation of AKT and PLCg.  
D The engagement of TAM receptors (TYRO3, AXL and MER) induces the 
recruitment of Cbl-b and the ubiquitinylation (ubi) of the protein tyrosine kinase 





Fig. 2. Modification of NK cell activation at the level of receptor-ligand 
interactions  
A A significant fraction of inhibitory Ly49 receptors is constitutively associated 
with MHC class I molecules in the plane of the NK cells’ membrane (in cis). These 
cis complexes do not contribute to inhibitory signaling. Thus, cis binding reduces the 
abundance of inhibitory receptors available to bind MHC class I on target cells, 
thereby lowering the threshold for NK cell activation. The absence of cis binding 
increases the threshold for NK cell activation.  
B NK cells are activated by the interaction of the DNAM-1 (CD226) receptor 
with CD155 ligand, which is counteracted by competitive binding of inhibitory 
TACTILE (CD96) to CD155. The activating receptor is disfavored due to a lower 
affinity for CD155 (indicated by a faint arrow) as compared to TACTILE (CD96). In 
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